InStride Co-Founder and Chief Medical Officer Dr. Mona Potter recognized as one of Modern Healthcare’s 2025 Innovator Award Honorees

BOSTON – April 14, 2025 – InStride Health, an outpatient provider of specialty anxiety and Obsessive-Compulsive Disorder (OCD) treatment for kids, teens and young adults, today announced that co-founder and Chief Medical Officer Dr. Mona Potter was recognized as a recipient of Modern Healthcare’s 2025 Innovator Awards. This award honors outstanding leaders and organizations driving innovation that improves care, achieves measurable results and contributes to clinical and financial goals.

“It’s an honor to be included amongst this group of medical professionals doing some of healthcare’s most forward-thinking, important work. This recognition speaks to the impact that InStride’s innovative pediatric mental health treatment program is having on young people and their families,” said Dr. Potter. “My inclusion on this list, and InStride’s successes, are a result of our entire team’s dedication to changing how we treat pediatric anxiety and OCD. I look forward to continuing that work and further expanding access to this life-changing program.”

The award for Dr. Potter follows other company milestones demonstrating InStride’s momentum and the effectiveness of its treatment. InStride’s mission is to make evidence-based cognitive behavioral therapy accessible to patients and families by accepting many major commercial insurance plans, including its latest in-network addition of Aetna in Connecticut and Massachusetts, announced in February. Last month, the company also announced the results of its second annual outcomes report, which showed that 98% of InStride graduates experienced overall clinical improvement and that 94% of graduates and 97% of caregivers, respectively, would recommend InStride to a friend.

“The ambitious work underway by our 2025 Innovators Awards’ honorees is producing exciting results that will lead to better results for patients and these organizations that are tackling the industry’s biggest challenges,” said Mary Ellen Podmolik, editor-in-chief of Modern Healthcare.

A detailed profile of Dr. Potter and the other honorees is included in the April 14, 2025 issue of Modern Healthcare’s magazine and online at ModernHealthcare.com/Innovators. To learn more about InStride, go to instride.health.

About InStride Health

InStride Health provides specialty outpatient care for kids, teens and young adults ages 7-22 living with anxiety, Obsessive-Compulsive Disorder (OCD), and related presentations. Co-founded by Harvard-trained clinicians, the InStride Health care model is grounded in evidence-based treatment, specifically cognitive behavioral therapy (CBT) with an emphasis on exposure therapy. Each young person is paired with a dedicated, multidisciplinary team of a psychiatrist, therapist, and an exposure coach that helps both the patient and their family. The young person is provided with real-time support as they face their fears in everyday moments and situations while developing skills and strategies for lasting change. InStride Health accepts most major insurance plans in Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, and Virginia.

About Modern Healthcare

Modern Healthcare is the most trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions. To learn more or subscribe, go to www.modernhealthcare.com/subscriptions.

Media Contact:

Matt Miller
V2 Communications
Instride@v2comms.com